Article
A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers
23 Mar 2023
Abstract excerpt
Introduction: Several recent studies pointed out that chromodomain-helicase-DNA-binding protein 1-like (CHD1L) is a putative oncogene in many human tumors. However, up to date, there is no pan-cancer analysis performed to study the different aspects of this gene expression and behavior in tumor tissues. Methods: Here, we applied several bioinformatics tools to make a comprehensive analysis for CHD1L. Firstly we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
